GlassScriptPhysician profile
Wesley R Heartfield
NPI 1134236516
$8,839.73
in general payments reported to CMS, 2019-2025
12 companies · $8,291 in 2025
The $8,291 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.09 · 2021: $42.46 · 2022: $22.25 · 2023: $75.74 · 2024: $381 · 2025: $8,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $983 · Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $983.08 |
| Food and Beverage | $764.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,091.26 | 2025 | |
| Inari Medical, INC. | $214.13 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $146.32 | 2023-2025 | Progrip, Ta, Ligasure |
| Teleflex LLC | $81.83 | 2025 | Deknatel |
| Merck Sharp & Dohme LLC | $74.86 | 2021-2023 | Bridion |
| Solventum Corporation | $52.69 | 2025 | Prevena |
| W. L. Gore & Associates, INC. | $47.26 | 2020-2024 | Gore Synecor Biomaterial |
| Becton, Dickinson and Company | $46.08 | 2024 | Arista Ah Flexitip |
| Davol INC. | $28.04 | 2024 | Phasix Mesh |
| Mallinckrodt Hospital Products INC. | $21.07 | 2021 | |
| Ethicon US, LLC | $19.65 | 2024 | Echelon Circular |
| Abbott Laboratories | $16.54 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Heartfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.